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Available online 12 February 2016Catestatin (CST), an endogenously small sympathoinhibitory peptide is capable of interfering with the major ce-
rebral neuroreceptor-blocking site, i.e.γ-aminobutyric acidA receptor (GABAAR) systemespecially in limbic brain
areas that are involved with feeding behaviors. The GABAARergic-related effects seem to derive from its interac-
tionwith othermolecular neuroreceptors such as dopaminergic, ghrelin and leptinergic. In this context, the pres-
ent study aimed to investigate probable feeding responses (eating and drinking) induced by treatment with CST
and the GABAAR antagonist bicucullin (BIC) alone or simultaneously (CST+ BIC) in the Syrian hibernating ham-
ster (Mesocricetus auratus)model. Hamsters that received these compounds via intracerebroventricular infusions
displayed notable variations of feeding and drinking bouts. In particular, an anorexigenic response was evident
following treatment with CST while BIC evoked a signiﬁcant increase of eating and drinking behaviors. Surpris-
ingly when both agents were given simultaneously, a predominating anorexigenic response was detected as
shown by evident CST-dependent reduction of feeding bouts. Contextually such behaviors, especially those
following the combined treatment were tightly correlated with the signiﬁcantly increased cerebral dopamine
receptor 1 (D1) plus reduced ghrelin receptor (GhsR) and leptin receptor (LepR) transcript levels. Overall, the an-
orexigenic effect of CST deriving from its tight interaction with GABAARs activity plus D1 and GhsR transcripts
tends to propose these neuronal elements as pivotal factors responsible for feeding disorders.




The novel small hydrophobic neuroactive sympathoinhibitory
peptide catestatin (CST), deriving from the proteolytic cleavage of
chromogranin A, contribute to autocrine and homeostatic mechanisms
driving from the in vitro catecholamine release of chromafﬁn cells and
neurons [29], while in vivo CST itself blocks the stimulation of both
secretion and transcription functions [30]. CST by acting on nicotinic
acetylcholine plusα2-adrenergic receptors is capable of evoking cardio-
vascular as well as metabolic effects, since it is capable of reducing lipidy Laboratory, Biology, Ecology
7036 Rende, CS, Italy.
naco).deposition plus increasing lipolysis and fatty acids oxidation [6]. It
appears that this highly novel peptide does not bind to a speciﬁc class
of neuroreceptors, and so its neuroactive responses tend to derive
from interactions with other major neuroreceptor systems [15, 18,
20]. In particular, CST is capable of interferingwith inhibitoryGABAergic
outputs [4] above all in cerebral areas involved with feeding behaviors
[25]. Of the different GABAergic sites, GABAAR is considered a versatile
receptor subtype due to its interaction with other neurotransmitter re-
ceptor systems and namely dopaminergic plus leptinergic (DAergic;
[12]). Together, these receptor systems not only control hypothalamic
feeding-related behaviors [11, 34, 38], but also grelin production [22,
24]. As far as the latter feeding-related factor is concerned, it is retained
a major orexigenic gut hormone regulating nutritional homeostatic
processes [26].
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area (VTA) to the nucleus accumbens have been considered a major
brain circuit controlling feeding rhythms via its rich interconnections
with hypothalamic pathways [8]. Indications deriving from this work
point to medial VTA-related DA production as a key signaling condition
capable of regulating eating habits through the involvement of DA re-
ceptors (D1 and D2; [41]). Moreover, studies have demonstrated that
the speciﬁc ghrelin receptor (GhsR) interacting with DAergic receptors
either attenuates or stimulates food intake [41]. In a similar fashion,
even the anorectic effects of leptinergic neurons tend to be correlated
to VTA DA inhibitory signals reducing feeding stimuli very probably
through the blocking actions of the Janus kinase/STAT neuronal path-
way [35].
On the basis of the above features, it was our intention to establish
the type of feeding relationship deriving from intracerebroventricular
(icv) treatment of the Syrian hibernating hamster (Mesocricetus
auratus) with two major cardio-regulative factors and namely, CST or
the GABAAergic antagonist bicucullin (BIC) given alone or together
(CST + BIC). The selection of this permissive hibernating rodent
model was based on its capability of tolerating stressful conditions,
which allowed us to study the different feeding and drinking responses,
after the stereotaxically central injection of drugs, during the euthermic
state [2, 32]. Contextually, the above experimental intentions were also
co-related to the expression variations of the main feeding-related
neuroreceptor systems and namely D1, D2, GhsR and leptin receptor
(LepR) of whole limbic regions that included hypothalamus, amygdala,
hippocampus and parietal cortex layers. Overall, indications deriving
from these results tend to propose CST plus GABAARs cross-talking
properties as major factor(s) operating during the different eating and
drinking intervals, which together with the above feeding related
neuroreceptors may constitute novel regulatory actors responsible for
feeding disorders.
2. Materials and methods
2.1. Animals, stereotaxic surgery and microinjections
For this study, Syrian golden hamsters (n = 23; 10 month-old;
Charles River, Italy) with free access to food and water were entrained
at room temperature (25 °C), under a 14 h light/10 h dark cycle in
order to allow them to adapt to their new conditions before surgery.
Subsequently hamsters, anesthetized intraperitoneally with urethane
(1.3–1.4 g/kg i.p.; Sigma Chemical Co., St. Louis, MO, USA), were placed
in a Stoelting stereotaxic instrument and the stainless steel guide can-
nula (CMA/Microdialysis AB, Stockholm, Sweden) was stereotaxically
implanted unilaterally directed toward and 1 mm above the icv space
(coordinates relative to lambda: AP +6 mm, ML +2.5 mm and
DV−4mm) according to the hamster stereotaxic atlas [33]. The cannu-
la was ﬁxed to the skull with acrylic dental cement and animals were
allowed 7 days to recover before behavioral studies.
Starting at day 7, infusionswere carried out through an inner cannu-
la (33 G) that extended 1 mm beyond the tip of the guide cannula,
which was connected to a Hamilton micro-syringe (1 μl) by polyethyl-
ene tubing. Animals were divided into four groups so that they were in-
fused with drugs in a same manner as previously described by us and
others: the ﬁrst received 1 μl of CST (50 μM; n=5; [17, 32]). The second
group received a dose of 1 μl of BIC (1.96 mM; n = 5; [43]); the third
group was infused with 1 μl of the combined treatment (CST + BIC;
n = 5) and the forth group that represents the control group (ctr;
n = 8) received 1 μl of saline solution (NaCl 0.9%). Treatment was con-
ducted every morning (at 9:00) for 7 days over a 60 s period plus a fur-
ther 60 s time-interval in which the solution was allowed to diffuse
from the cannula. The effects of the different drug treatments were
compared with respect to ctrs. Animal maintenance and experimental
procedures were carried out in compliance with the ethical provisions
for Care and Use of Laboratory Animals reported in the legislative lawn°116 (27-01-1992) and authorized by the National Committee of the
Italian Ministry of Health.2.2. Behavioral analyses
In the present study, all experiments were performed between 9:00
and 15:00, with hamsters handled 3 min each day prior to behavioral
testing. Hamsters were allowed a thirty-minute interval after drug
infusion before being checked for the most common feeding behav-
iors during a 20 min interval, 3 times a day for 7 days. The following
feeding parameters were evaluated: eating, drinking plus body
weight variations [21, 32]. All behaviors were recorded by a webcam
placed perpendicularly at 60 cm above the cage ﬂoor as previously
described [2]. After which, all animals were sacriﬁced, whole limbic
areas were removed and then stored at−80 °C for further investiga-
tions. At the end of the study, some ctr animals (n = 3) received 1 μl
of 1% methylene blue solution in order to verify that icv injections
were conducted correctly.2.3. RNA extraction, reverse transcription and real time PCR
For this study the expression patterns of D1, D2, GhsR and LepR,
which resulted to be strongly connected with feeding behaviors
[26, 34, 41] were evaluated. Total RNA was extracted from hypothal-
amus, amygdala, hippocampus and parietal cortex layers of treated
and ctr hamsters, using TRI-Reagent (Sigma-Aldrich, USA) according
to the manufacturer's instructions. Contaminating genomic DNAwas
removed by treatment with DNase (Ambion, Life Technologies) and
RNA concentration was measured with a NanoDrop spectrophotom-
eter [1]. 1 μg RNA was then reverse transcribed with High Capacity
cDNA Reverse Transcriptase (Life Technologies). Real time PCR for
D1, D2, GhsR and LepR, was carried out on Applied Biosystem 7500
Real Time System using SYBR Select Master Mix assay (Applied
Biosystem, Courtaboeuf). Gene-speciﬁc primers were designed, accord-
ingly to GenBank published sequences using Primer Express software
version 3.0 (Applied Biosystems): D1 forward primer 5′-GGGATTTCTC
CTTTCGCATTC-3′; D1 reverse primer 5′-CCAGGAGAGTGGACAGGA
TGA-3′; D2 forward primer 5′-AAGCGCCGAGTCACTGTCA-3′; D2 re-
verse primer 5′-GTGGGCAGGAGATGGTGAAG-3′; GhsR forward primer
5′-GCTGGAGCCTAACGTCACTAGAG-3′; GhsR reverse primer 5′-CGTC
CGTCAGAGAGTCATTGC-3′; LepR forward primer 5′-GGGCAGAGCAAG
CACATACTG-3′; LepR reverse primer 5′-CAAGGGAAGCACCAATGGAA-
3′. The primers pairs of the housekeeping β-actin gene, utilized as a
reference endogenous control, were: forward 5′-TATCGGCAATGAGC
GGTTCC-3′; reverse 5′-AGCACTGTGTTGGCATAGAGG-3′. The amount
of target cDNA was calculated by comparative threshold (Ct) method
and expressed applying 2−ΔΔCt method [28] using β-actin gene as a
reference endogenous control. All experiments were carried out in
triplicates.2.4. Statistical analysis
Behavioral performances of hamsters treated with CST, BIC and
CST+ BIC were evaluated using a Etholog 2.2 program [37] and the dif-
ferent behaviors (value ± s.e.m.) were compared to ctrs using ANOVA
followed by a post hoc multiple range Newman-Keul's test when p-
value b0.05. *p b 0.05, **p b 0.01, ***p b 0.001. At the same time the ef-
fects of CST plus CST + BIC were compared to effects of BIC ap b 0.05,
cp b 0.001. mRNA levels (arbitrary units ± s.e.m.) of hamsters treated
with CST, BIC and CST + BIC were also determined by ANOVA followed
by a post hoc multiple range Newman-Keul's test when p-value b0.05.
a,⁎p b 0.05, **p b 0.01, c,***p b 0.001, by using statistical software
GraphPad Prism Software, version 5.0.
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3.1. Behavioral analyses
Icv infusionswith CST, BIC or CST+BIC supplied differentiated feed-
ing performances of our hibernating rodent model. Hamsters infused
with the small neuroactive sympathoinhibitory peptide (CST) exhibited
a very evident reduction (F3,12 = 6.01; p b 0.001) of drinking frequen-
cies (−83%), plus a moderate (p b 0.05) decrease of eating frequencies
with respect to ctrs (−57%; Fig. 1a). This phenomenon appeared to be
related to a notable reduction of time performing such a behavior
(F3,12 = 5.78 p b 0.01) as pointed out by extremely fewer (p b 0.001)
eating (−83%) plus drinking (−80%) bouts with respect to ctrs
(Fig. 1b). On the other hand, despite the GABAAR antagonist BIC drove
hamsters (F3,12 = 5.93; p b 0.01) to eat (+62%) and drink (+71%) in
a greater manner than that of ctrs, when it was compared with either
CST alone or the combined treatment (CST + BIC), it seemed that
these latter treatments caused hamsters to extremely reduce drinking
(−115% and−93%, respectively) and eating (−91% and−54%, respec-
tively) frequencies, despite being of a lesser entity for the combined
treatment of this latter behavior (Fig. 1a). However, it was evident
that BIC was responsible for a moderate amount of time spent consum-
ing food (+34%) whereas such a treatment did not modify drinking
time with respect to ctrs (Fig. 1b). The effects of the other two drugsFig. 1. Hamsters behaviors: a) frequency of eating and drinking (% ± s.e.m.); b) time
(sec ± s.e.m.) spent in eating and drinking bouts induced by icv infusion (5/each
treatment) with, CST (50 μM), BIC (1.96 mM) or CST + BIC versus ctrs (treatment with
NaCl). The behavioral changes were determined by ANOVA plus a post hoc Newman–
Keul's test with respect to ctrs when p b 0.05. *p b 0.05, **p b 0.01, ***p b 0.001.
Moreover signiﬁcant variations of CST and CST + BIC treatments with respect to BIC
treated hamsters were indicated, where necessary, with letters. ap b 0.05, cp b 0.001.treatments accounted for a notably reduced amount of time (~−81%)
spent consuming food and water with respect to ctrs. Even in this case
when the greater effects of BIC (versus ctrs) were compared to CST
given alone or concomitantly, it appeared that such treatments inverted
the actions evoked by BIC as pointed out by the substantially reduced
time spent eating (−107% and −120%, respectively) and drinking
(−95% and−110%, respectively).
Regarding body weight variations it seemed that although BIC treat-
ed hamsters featured an increased bodyweight, at the end of the behav-
ioral observations (day 7), CST and above all the co-treatment led to a
reduction of this same effect (Fig. 2a). Speciﬁcally, a very signiﬁcant re-
duction (F3,12= 5.98; p b 0.001) of bodyweight (−400%)was obtained
not only for CST + BIC-treated hamsters with respect to ctrs (Fig. 2b)
but also for CST alone, despite being numerically lower (−250%). As
far as treatment with BIC alone was concerned, hamsters displayed a
very elevated increase (+150%) of body weight with respect to ctrs.
3.2. D1, D2, GhsR and LepR expression variations
The ﬁrst molecular indications evoked by icv infusions of CST, BIC
and CST+ BIC in our rodentmodel pointed to differentiated expression
capacities of D1 and D2 along with the major feeding-related
neuroreceptors (GhsR plus LepR) with respect to ctrs. This was the
case of the notably high transcript levels (F3,12 = 5.99; p b 0.001) of
the DAergic receptor subtype D1 (+118%) being largely detected in in
hypothalamus, amygdala, hippocampus and parietal cortex layers of
BIC treated hamsters with respect to ctrs, while only relatively elevated
transcript levels were detected in these same brain areas of both CST
plus CST+ BIC treated animals (~+77%; Fig. 3a). Conversely, a moder-
ate reduction was, instead, reported for both CST and CST + BIC treat-
ments (F3,12 = 5.91; p b 0.01) when they were compared to BICFig. 2. Hamsters body weight variations (grams ± s.e.m.) evoked by icv infusion (5/each
treatment) with NaCl, CST (50 μM), BIC (1.96 mM) or CST + BIC during the 7 days of
observations (a). b) Each bar represents Δbody weight (grams ± s.e.m.). Body weight
changes were determined by ANOVA plus a post hoc Newman–Keul's test when
p b 0.05. *p b 0.05, **p b 0.01, ***p b 0.001.
Fig. 3. D1 (a), D2 (b), GhsR (c) and LepR (d) mRNA expression levels (represented as
arbitrary units ± s.e.m.) in hamsters treated with CST (50 μM), BIC (1.96 mM) and
CST + BIC were compared to ctr (NaCl) or BIC using ANOVA plus a post hoc Newman–
Keul's test when p b 0.05 as indicated for statistical description of Fig. 1.
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type (D2) was concerned, only a moderate up-regulation was reported
for BIC with respect to ctrs (+48%; Fig. 3b) while the other two treat-
ments did not cause signiﬁcant variations. For this same receptor
subtype it seemed that a notably down-regulatory trend was detected
for CST (−86%) while only a moderate reduction was reported for
CST + BIC (−53%).It was worthy to note that a rather evident down-regulatory trend
(F3,12= 5.94; p b 0.01) of GhsR expression characterized all treatments,
as displayed by negative percentage values registered in all whole lim-
bic areas of CST + BIC (−80%), CST (−70%) and BIC (−44%) treated
hamsters with respect to ctrs (Fig. 3c). This similar down-regulatory
trend was also detected for hypothalamus, amygdala, hippocampus
and parietal cortex layers of CST + BIC (−74%) and CST (−40%) with
respect to BIC treatment. Contextually, even the notably reduced LepR
transcript levels (F3,12 = 5.92; p b 0.01), continued to be reduced de-
spite being of a moderate nature, this time for CST + BIC (−53%) and
CST (−34%) treatments with respect to ctrs (Fig. 3d). Interestingly, a
similar reducing trend still continued to characterize the effects of
both treatments when compared to BIC treated hamsters as pointed
out by substantially (−81%) and moderately (−38%) decreased
expression levels, respectively, of LepRmRNAs in hypothalamus, amyg-
dala, hippocampus and parietal cortex layers.
4. Discussion
The principal ﬁnding of this study regarded eating and drinking
variations being caused by CST and GABAAergic system evoking, via
cross-talking mechanisms, altered expression capacities of the main
feeding-related neuroreceptors (D1, D2, GhsR and LepR). This dimin-
ished eating effect is particularly evident for the anti-obesity role of
CST, in which other studies reported its capacity of reducing lipid depo-
sition plus increasing lipolysis and fatty acids oxidation thereby leading
mice to fewer eating and drinking bouts with consequent decreased
body weight [6]. A feature that is in good agreement with diminished
body weight detected during euthermic conditions of our rodent
model very likely due, in this case, to the concomitant down regulation
of ORX2R in themain hypothalamic feeding center (lateral hypothalam-
ic area) and to its up-regulated levels in the anorexigenic sites (ventro-
medial and supraoptic nuclei) of the same brain region [32]. In addition
the feeding effects evoked by CST tend to go in the same direction of the
very evident up-regulation of D1 neuroreceptors of the brain areas con-
sidered in the present study. Such a relationship appears to be strongly
supported by the high expression levels of D1 accounting for elevated
intracellular levels of cAMP in the central amygdalar nucleus, which
by favoring an anorexigenic effect via modulation of protein kinase A
[7, 39] tend to reduce frequency and duration of feeding intervals in
hamsters [32].
The results of the present study tend to also demonstrate that the
above behaviors for CST-treated hamsters appear to be also related
with down-regulatory trends of GhsR and LepR mRNA levels. In the
case of the former receptor subtype this should not be so surprising
since previous studies provided inhibitory feeding behaviors occurring
mainly via diminished GhsR levels [13]. On the other hand, while the
down-regulation of the latter factor seems to represent a contrasting
feature in view of its anorexigenic role [14], it may very well be that
hamsters treated with CST favor reductions of circulating catechol-
amines thus leading to reduced LepR transcriptional abilities as a conse-
quence of elevated leptin levels [6].
Similarly, even the greater blocking GABAergic effects, over ctrs,
tend to follow the above trend thereby supporting enhancing CST-
dependent actions especially in the case of increased body weight oc-
curring contextually to the up-regulated D2 subtype mRNA levels. This
aspect seems to be strongly supported not only by high D2 levels ac-
counting for greater food intake and thus increased bodyweight as indi-
cated by pro-obesity plus metabolic disorders of the Korean National
dietary guidelines [40], but also from stimulated feeding behavior in
free-feeding rats by icv BIC treatment of the notable satiety center-
ventromedial hypothalamic nucleus containing denseGABAergic inputs
[10]. Indeed, from a molecular point of view, D2-like receptors supply a
10- to 100-fold greater afﬁnity for DA than D1-like family [7] that turn
out to be a determining factor for the consumption of high food quanti-
ties, in a similar manner to that evoked by ghrelin-treated animals [44].
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treated with both ghrelin plus leptin along with elevated D2 mRNAs
tend to further strengthen the major role played by this DAergic recep-
tor subtype, as pointed out by its reduced levels being responsible for
the consumption of less food [9, 36]. In addition the lack of appetite, in
these animals may be due to elevated concentrations of D1 subtype,
which recently has shown to be tightly correlated to notable reductions
of feedingbehaviors in rats and consequently a very evident loss of body
weight [7, 39].
It was particularly interesting to observe that still greater CST effects
prevailed when hamsters were also treated with BIC as displayed by
very great reduced feeding and drinking behaviors plus body weight.
Indeed, a reduction of these appetitive behaviors, aside being associated
with an up-regulation of D1mRNA levels seem to also rely on the down-
regulatory trend of GhsR transcripts. As far as the altered GABAergic-
dependent feeding and drinking behaviors occurring in presence of
CST are concerned, they seem to behave in a similar manner to the di-
rect cardio-sympathetic effects of hypothalamic neurons [20]. In this
particular case, treatment of such a diencephalic brain station with BIC
and the sympathoinhibitory peptide accounted for a synergic reduction
of arterial blood pressure [20, 27], which is in line also with the recent
potent synergic effects of CST and PACAP on barosensitivity and
chemosensitivity events [19]. At the same time, GABAergic effects on
CST treated animals may be achieved by other neuronal systems such
as cholinergic ﬁbers [31], as suggested by their activation within
mesolimbic sites leading to modiﬁed feeding and drinking behaviors
[3]. In this same context even reduced orexigenic GhsR expression
levels may be exerting similar effects together with hypothalamic neu-
ropeptide Y neurons thereby accounting for reduced feeding stimuli
[23] as observed in our rodent model.
5. Conclusions
The data of this study provided us with interesting indications re-
garding the blocking effects.
of CST and GABAAergic systems on feeding and drinking behaviors.
In particular the anti-obesity role of CST detected not only when given
alone but also co-infused with BIC may have accomplished such behav-
ioral events via activation of DAergic neuronal ﬁbers. Additionally, the
simultaneous up-regulation of D1 and reduced orexigenic GhsR mRNA
levels being related to reduced feeding behaviors very probably via
the inhibition of the protein kinase A as previously reported in transgen-
ic mice, in which the selective inhibition of this protein promoted a
hypophagic condition [45]. Conversely, the surprisingly reduced
mRNA levels of the anorexigenic LepR may be evoked, at least in part,
by the increased production of adipocyte-related leptin, which by
exerting a prevailing CSTergic brake on α-adrenergic signals account
for the desensitization of LepRs. At the same time, the blocking effects
of inhibitory GABAAergic currents resulted to be strongly linked with
the up-regulation of D2 that in turn constitutes a major factor favoring
food intake [9, 36]. In this case the predominating actions of CST over
GABAARs in the combined treatmentmay very well be due to the inhib-
itory activity of this sympathoinhibitory peptide on the GABAARergic
site that by promoting an anorexigenic effect leads hamsters to eat
less [5], which is in line with hypothalamic melanocortin promoting
apolipoprotein E-dependent sympathoinhibitory effects suppressing
food intake in mice and rats [5, 16, 42]. We are still at the beginning
but the present indications proposing CST and GABAARs activities, as
major novel neuronal signals operating during feeding bouts may con-
stitute therapeutic alternatives for treating feeding disorders.
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